BCRABL1 Kinase Domain Mutation Analysis IRMA cost NGN 300000
Achondroplasia FGFR3 Full Gene Sequence Analysis cost NGN 600000 Achondroplasia FGFR3 Full Gene Sequence Analysis Original price was: ₦ 800,000.Current price is: ₦ 600,000.
Beta Thalassemia HBB Full Gene Analysis Single cost NGN 150000 Beta Thalassemia HBB Full Gene Analysis Single Original price was: ₦ 200,000.Current price is: ₦ 150,000.
Sale!

BCRABL1 Kinase Domain Mutation Analysis IRMA

Original price was: ₦ 400,000.Current price is: ₦ 300,000.

-25%

The BCRABL1 Kinase Domain Mutation Analysis IRMA is a crucial diagnostic test that detects mutations in the BCR-ABL1 gene, which are associated with certain types of leukemia. Priced at 300,000 NGN, this test is vital for patients experiencing symptoms like fatigue, unexplained bruising, or recurrent infections. Understanding your results can guide treatment options and improve outcomes.

Book your test online and get free home sample collection

  • 100% Accurate Test Results
  • Get Tested at Nigeria No1 Genetic DNA Lab
  • Customer support Call 08110567037
Guaranteed Safe Checkout

BCRABL1 Kinase Domain Mutation Analysis IRMA

Introduction to the Test

The BCRABL1 Kinase Domain Mutation Analysis IRMA is a specialized genetic test that plays a significant role in diagnosing chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). This test analyzes mutations in the BCR-ABL1 gene, which can influence the effectiveness of targeted therapies. Identifying these mutations is crucial for tailoring treatment plans and improving patient outcomes.

What the Test Measures

This test specifically detects mutations in the kinase domain of the BCR-ABL1 fusion protein. These mutations can lead to resistance against certain tyrosine kinase inhibitors, making it essential for determining the most effective treatment strategy for patients.

Who Should Consider This Test?

Patients who should consider the BCRABL1 Kinase Domain Mutation Analysis IRMA include:

  • Individuals diagnosed with chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL).
  • Patients experiencing treatment failure or resistance to therapy.
  • Those with symptoms such as fatigue, unexplained bruising, or recurrent infections.

Benefits of Taking the Test

The benefits of undergoing the BCRABL1 Kinase Domain Mutation Analysis IRMA include:

  • Accurate identification of genetic mutations that may affect treatment efficacy.
  • Guidance for healthcare providers in selecting the most appropriate therapy.
  • Enhanced monitoring of treatment response and disease progression.

Understanding Your Results

Results from the BCRABL1 Kinase Domain Mutation Analysis IRMA will indicate the presence or absence of mutations in the BCR-ABL1 gene. A healthcare provider will help interpret the results and discuss potential implications for treatment options. It is essential to follow up with your doctor to understand your results fully.

Test Pricing

Price Type Amount (NGN)
Discount Price 300,000
Regular Price 400,000

Book Your Test Today!

To book the BCRABL1 Kinase Domain Mutation Analysis IRMA, please contact us via phone or WhatsApp at +2348110567037. Ensure you have a doctor’s prescription for this test, except for cases involving surgery, pregnancy, or those planning to travel abroad.

Test Details

  • Turnaround Time: 2-3 weeks
  • Sample Type: Bone marrow / Peripheral blood (Transport immediately)
  • Test Components: EDTA Vacutainer (2ml)
  • Pre-Test Instructions: A doctor’s prescription is required for the BCR-ABL1 Kinase Domain Mutation Analysis IRMA.
SKU: 0148ee3d5d18 Category:

Related products